Bokus

Johnson Y. N. Lau – författare

Visar alla böcker från författaren Johnson Y. N. Lau. Handla med fri frakt och snabb leverans.

7 produkter

  1. Johnson Y. N. Lau - Hepatitis C Protocols, Häftad. Tillgänglighet: Lägg i varukorg

    Hepatitis C Protocols

    Av Johnson Y. N. Lau

    Häftad, 2013

    566 kr

    Lägg i varukorg

    The identification of hepatitis C virus by Michael Houghton and his c- leagues at the Chiron Corporation nearly years ago represented a technical tour de force of modern molecular medicine. This breakthrough not only unearthed the causative agent of non-A non-B hepatitis that had eluded the best of …

  2. Robert K. Hamatake, Johnson Y. N. Lau - Hepatitis B and D Protocols, Inbunden. Tillgänglighet: Lägg i varukorg

    Hepatitis B and D Protocols

    Volume 1: Detection, Genotypes, and Characterization

    Av Robert K. Hamatake, Johnson Y. N. Lau

    Inbunden, 2004

    1685 kr

    Lägg i varukorg

    Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically …

  3. Johnson Y. N. Lau, Robert Kiyoshi Hamatake, Robert K. Hamatake, Johnson Y. N. Lau - Hepatitis B and D Protocols, Inbunden. Tillgänglighet: Lägg i varukorg

    Hepatitis B and D Protocols

    Volume 2: Immunology, Model Systems, and Clinical Studies

    Av Johnson Y. N. Lau, Robert Kiyoshi Hamatake m. fl.

    Inbunden, 2004

    1685 kr

    Lägg i varukorg

    Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically …

  4. Johnson Y. N. Lau - Hepatitis C Protocols, E-bok. Tillgänglighet: Lägg i varukorg

    Hepatitis C Protocols

    Av Johnson Y. N. Lau

    E-bok, 2008

    755 kr

    Lägg i varukorg

    The identification of hepatitis C virus by Michael Houghton and his c- leagues at the Chiron Corporation nearly years ago represented a technical tour de force of modern molecular medicine. This breakthrough not only unearthed the causative agent of non-A non-B hepatitis that had eluded the best of …

  5. Robert K. Hamatake, Johnson Y. N. Lau, Robert K. Hamatake, Johnson Y. N. Lau - Hepatitis B and D Protocols. Tillgänglighet: Lägg i varukorg

    Hepatitis B and D Protocols

    Volume 1: Detection, Genotypes, and Characterization

    Av Robert K. Hamatake, Johnson Y. N. Lau m. fl.

    2014

    2563 kr

    Lägg i varukorg

    For volume 1: A broad-ranging collection of core techniques for the study of HBV and HDV infections and for the development of therapies to treat them. In this first of two volumes Detection, Genotypes, and Characterization, the authors focus on readily reproducible molecular methods for the …

  6. Johnson Y. N. Lau, Robert K. Hamatake - Hepatitis B and D Protocols, E-bok. Tillgänglighet: Lägg i varukorg

    Hepatitis B and D Protocols

    Volume 2: Immunology, Model Systems, and Clinical Studies

    Av Johnson Y. N. Lau, Robert K. Hamatake

    E-bok, 2008

    1634 kr

    Lägg i varukorg

    Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically …

  7. Robert K. Hamatake, Johnson Y. N. Lau - Hepatitis B and D Protocols, Häftad. Tillgänglighet: Lägg i varukorg

    Hepatitis B and D Protocols

    Volume 2: Immunology, Model Systems, and Clinical Studies

    Av Robert K. Hamatake, Johnson Y. N. Lau

    Häftad, 2010

    1237 kr

    Lägg i varukorg

    Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically …